Read more in the app
From lab to clinic: CU Anschutz launches Phase 1 clinical trial of promising combination therapy for resistant ovarian cancer - EurekAlert!
CU Anschutz part of multi-state study: smartphone app cuts repeat suicide attempts by over half after hospital discharge - EurekAlert!
CU Anschutz develops first validated tool to measure performance in bone-anchored prosthesis users after amputation - EurekAlert!
CU Anschutz called a 'case study' for commercializing medical breakthroughs
CU Anschutz scientists reverse deadly impacts of asthma in mice
